Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Agios Pharmaceuticals beat estimated earnings by 3.87%, reporting an EPS of $-1.74 versus an estimate of $-1.81.
Revenue was up $832.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 5.7% increase in the share price the next day.
Here's a look at Agios Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.69 | -1.59 | -1.41 | -1.32 |
| EPS Actual | -1.74 | -1.56 | -1.44 | -1.31 |
| Revenue Estimate | 560.00K | 2.60M | 2.48M | 44.60M |
| Revenue Actual | 0 | 0 | 0 | 0 |
To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
